2025
SJR Q3
JCR Q3 · 1,8
171 eşleşen makale
SCIE
Dergi ayrıntısı
Canadian Journal of Physiology and Pharmacology
- Yayıncı
- National Research Council of Canada
- Ülke
- Canada · Northern America
- Tür
- journal
- ISSN
-
0008421212057541
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,468
- Quartile Q3
- H-Index 101
- Atıf/yayın 1,83
- Doküman (3y) 240
- Atıf (3y) 406
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,8
- 5Y JIF 1,8
- JCI 0,51
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Medicine (miscellaneous) Q3
- Pharmacology Q3
- Physiology Q3
- Physiology (medical) Q3
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Pharmacology & Pharmacy | Physiology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,468 | 1,8 | 1,8 | 0,51 | Q3 | 101 |
| 2024 | Q3 | Q4 | 0,45 | 1,4 | 1,7 | 0,56 | Q3 | 99 |
| 2023 | Q3 | Q3 | 0,499 | 1,7 | 1,8 | 0,63 | Q3 | 99 |
| 2022 | Q3 | Q3 | 0,497 | 2,1 | 2,1 | 0,65 | Q2 | 99 |
| 2021 | Q2 | Q4 | 0,517 | 2,2 | 2,4 | 0,64 | Q3 | 99 |
| 2020 | Q3 | Q3 | 0,559 | 2,3 | 2,5 | 0,65 | Q3 | 99 |
| 2019 | Q2 | Q3 | 0,583 | 1,9 | 2,1 | 0,69 | Q2 | 99 |
| 2018 | — | Q3 | — | 2 | 2,1 | 0,68 | Q3 | — |
| 2017 | Q2 | Q3 | 0,724 | 2,2 | 1,9 | 0,66 | Q3 | 99 |
| 2016 | Q2 | Q3 | 0,56 | 1,8 | 1,7 | — | — | 99 |
| 2015 | Q2 | Q3 | 0,697 | 1,7 | 1,7 | — | — | 99 |
| 2014 | Q2 | Q3 | 0,719 | 1,8 | 1,8 | — | — | 99 |
| 2013 | Q2 | Q3 | 0,69 | 1,5 | 1,7 | — | — | 99 |
| 2012 | Q2 | Q3 | 0,648 | 1,6 | 1,7 | — | — | 99 |
| 2011 | Q2 | Q3 | 0,725 | 2 | 1,9 | — | — | 99 |
| 2010 | Q2 | Q3 | 0,715 | 1,8 | 1,9 | — | — | 99 |
| 2009 | — | Q3 | — | 1,3 | 1,6 | — | — | — |
| 2008 | — | Q3 | — | 1,8 | 1,6 | — | — | — |
| 2007 | — | Q3 | — | 1,6 | 1,6 | — | — | — |
| 2006 | — | Q3 | — | 1,4 | — | — | — | — |
| 2005 | — | Q3 | — | 1,5 | — | — | — | — |
| 2004 | — | Q3 | — | 1,6 | — | — | — | — |
| 2003 | — | Q3 | — | 1,4 | — | — | — | — |
| 2002 | — | Q3 | — | 1,3 | — | — | — | — |
| 2001 | — | Q3 | — | 1,3 | — | — | — | — |
| 2000 | — | Q3 | — | 1,2 | — | — | — | — |
| 1999 | — | Q2 | — | 1,5 | — | — | — | — |
| 1998 | — | Q2 | — | 1,2 | — | — | — | — |
| 1997 | — | Q2 | — | 1,3 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 258/356 |
| 2025 | PHYSIOLOGY | SCIE | Q4 | Q4 | 73/89 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 280/352 |
| 2024 | PHYSIOLOGY | SCIE | Q4 | Q4 | 75/87 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 251/354 |
| 2023 | PHYSIOLOGY | SCIE | Q4 | Q3 | 64/85 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q2 | 212/278 |
| 2022 | PHYSIOLOGY | SCIE | Q3 | Q3 | 57/79 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 221/279 |
| 2021 | PHYSIOLOGY | SCIE | Q4 | Q3 | 64/81 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 208/276 |
| 2020 | PHYSIOLOGY | SCIE | Q3 | Q3 | 56/81 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 200/271 |
| 2019 | PHYSIOLOGY | SCIE | Q3 | Q3 | 53/81 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 178/267 |
| 2018 | PHYSIOLOGY | SCIE | Q3 | Q3 | 54/81 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 156/261 |
| 2017 | PHYSIOLOGY | SCIE | Q3 | Q3 | 49/83 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 178/257 |
| 2016 | PHYSIOLOGY | SCIE | Q3 | — | 55/84 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 174/255 |
| 2015 | PHYSIOLOGY | SCIE | Q3 | — | 60/83 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 165/255 |
| 2014 | PHYSIOLOGY | SCIE | Q3 | — | 57/83 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 172/256 |
| 2013 | PHYSIOLOGY | SCIE | Q4 | — | 61/81 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 176/261 |
| 2012 | PHYSIOLOGY | SCIE | Q3 | — | 56/80 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 145/261 |
| 2011 | PHYSIOLOGY | SCIE | Q3 | — | 49/79 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 150/252 |
| 2010 | PHYSIOLOGY | SCIE | Q3 | — | 48/78 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 176/237 |
| 2009 | PHYSIOLOGY | SCIE | Q4 | — | 60/75 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 138/219 |
| 2008 | PHYSIOLOGY | SCIE | Q3 | — | 45/74 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 135/205 |
| 2007 | PHYSIOLOGY | SCIE | Q3 | — | 47/78 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 136/199 |
| 2006 | PHYSIOLOGY | SCIE | Q3 | — | 55/78 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 117/193 |
| 2005 | PHYSIOLOGY | SCIE | Q3 | — | 52/75 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 104/187 |
| 2004 | PHYSIOLOGY | SCIE | Q3 | — | 39/74 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 112/185 |
| 2003 | PHYSIOLOGY | SCIE | Q3 | — | 47/74 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 106/188 |
| 2002 | PHYSIOLOGY | SCIE | Q3 | — | 46/73 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 105/186 |
| 2001 | PHYSIOLOGY | SCIE | Q3 | — | 45/74 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 95/181 |
| 2000 | PHYSIOLOGY | SCIE | Q3 | — | 45/76 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 68/175 |
| 1999 | PHYSIOLOGY | SCIE | Q2 | — | 30/74 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 82/178 |
| 1998 | PHYSIOLOGY | SCIE | Q2 | — | 32/67 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 71/157 |
| 1997 | PHYSIOLOGY | SCIE | Q2 | — | 28/65 |